Nannu'S Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 31-05-2024
- Paid Up Capital ₹ 0.10 M
as on 31-05-2024
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.98 M
as on 31-05-2024
- Satisfied Charges ₹ 0.40 M
as on 31-05-2024
- Revenue 159.53%
(FY 2020)
- Profit 201.56%
(FY 2020)
- Ebitda 185.60%
(FY 2020)
- Net Worth 75.78%
(FY 2020)
- Total Assets 210.33%
(FY 2020)
About Nannu'S Pharmaceuticals
The Company is engaged in the Non-Profit Organizations Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.98 M. The company has closed loans amounting to ₹0.40 M, as per Ministry of Corporate Affairs (MCA) records.
Nilesh Pimple and Shraddha Pimple serve as directors at the Company.
- CIN/LLPIN
U85310MH2018PTC304924
- Company No.
304924
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Feb 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nannu'S Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nilesh Pimple  | Managing Director | 08-Feb-2018 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shraddha Pimple | Director | 08-Feb-2018 | Current |
Financial Performance of Nannu'S Pharmaceuticals.
Nannu'S Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 159.53% increase. The company also saw a substantial improvement in profitability, with a 201.56% increase in profit. The company's net worth Soared by an impressive increase of 75.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nannu'S Pharmaceuticals?
Unlock access to Nannu'S Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 17 Dec 2020 | ₹0.98 M | Open |
Others Creation Date: 30 Apr 2019 | ₹0.40 M | Satisfied |
How Many Employees Work at Nannu'S Pharmaceuticals?
Unlock and access historical data on people associated with Nannu'S Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nannu'S Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nannu'S Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
